Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 44 of the 46 references it cites were found in a registry or an index.

Time spent at blood pressure target and the risk of death and cardiovascular diseases

Open access

Abstract

BACKGROUND: The time a patient spends with blood pressure at target level is an intuitive measure of successful BP management, but population studies on its effectiveness are as yet unavailable. METHOD: We identified a population-based cohort of 169,082 individuals with newly identified high blood pressure who were free of cardiovascular disease from January 1997 to March 2010. We used 1.64 million clinical blood pressure readings to calculate the TIme at TaRgEt (TITRE) based on current target blood pressure levels. RESULT: The median (Inter-quartile range) TITRE among all patients was 2.8 (0.3, 5.6) months per year, only 1077 (0.6%) patients had a TITRE ≥11 months. Compared to people with a 0% TITRE, patients with a TITRE of 3-5.9 months, and 6-8.9 months had 75% and 78% lower odds of the composite of cardiovascular death, myocardial infarction and stroke (adjusted odds ratios, 0.25 (95% confidence interval: 0.21, 0.31) and 0.22 (0.17, 0.27), respectively). These associations were consistent for heart failure and any cardiovascular disease and death (comparing a 3-5.9 month to 0% TITRE, 63% and 60% lower in odds, respectively), among people who did or did not have blood pressure 'controlled' on a single occasion during the first year of follow-up, and across groups defined by number of follow-up BP measure categories. CONCLUSION: Based on the current frequency of measurement of blood pressure this study suggests that few newly hypertensive patients sustained a complete, year-round on target blood pressure over time. The inverse associations between a higher TITRE and lower risk of incident cardiovascular diseases were independent of widely-used blood pressure 'control' indicators. Randomized trials are required to evaluate interventions to increase a person's time spent at blood pressure target.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0202359

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Definition of newly identified hypertension, average annual time at target (TITRE) and fatal and non-fatal cardiovascular events. 1 BP <140/90 mmHg, or <150/90 for patients aged 60 years or more without diabetes and chronic kidney disease. BP: blood pressure. CVD: cardiovascular disease. 2 For each patient, the days that blood pressure was at target between two consecutive measures were summed to calculate the percent time at target for each follow-up year, and then averaged over follow-up years. Details are described in S1 Method. 3 Incident cardiovascular disease include: myocardial infarction, stroke (including ischemic stroke, intracerebral hemorrhage and sub-arachnoid hemorrhage), heart failure, angina, atrial fibrillation, transient ischemic attack, peripheral artery disease, abdominal aortic aneurysm and cardiovascular and non-cardiovascular mortality.) It is unclear to what the (1) refers to in the figure.
Fig 1 Definition of newly identified hypertension, average annual time at target (TITRE) and fatal and non-fatal cardiovascular events. 1 BP <140/90 mmHg, or <150/90 for patients aged 60 years or more without diabetes and chronic kidney disease. BP: blood pressure. CVD: cardiovascular disease. 2 For each patient, the days that blood pressure was at target between two consecutive measures were summed to calculate the percent time at target for each follow-up year, and then averaged over follow-up years. Details are described in S1 Method. 3 Incident cardiovascular disease include: myocardial infarction, stroke (including ischemic stroke, intracerebral hemorrhage and sub-arachnoid hemorrhage), heart failure, angina, atrial fibrillation, transient ischemic attack, peripheral artery disease, abdominal aortic aneurysm and cardiovascular and non-cardiovascular mortality.) It is unclear to what the (1) refers to in the figure.CC BY · PubMed Central
Fig 2 Time at target (TITRE) distribution in patients with recorded TITRE (N = 150130). *Median 2.8 (0.3, 5.6) months.
Fig 2 Time at target (TITRE) distribution in patients with recorded TITRE (N = 150130). *Median 2.8 (0.3, 5.6) months.CC BY · PubMed Central
Fig 3 Patient characteristics and their association with a higher or lower TITRE (%).
Fig 3 Patient characteristics and their association with a higher or lower TITRE (%).CC BY · PubMed Central
Fig 4 Associations between categorical time at target (TITRE) and primary (composite of cardiovascular mortality, myocardial infarction and stroke, incident heart failure and any cardiovascular diseases) and secondary (stable angina, peripheral artery disease, and all-cause mortality) study endpoints (n = 169082).
Fig 4 Associations between categorical time at target (TITRE) and primary (composite of cardiovascular mortality, myocardial infarction and stroke, incident heart failure and any cardiovascular diseases) and secondary (stable angina, peripheral artery disease, and all-cause mortality) study endpoints (n = 169082).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 46 references

Cited by

See all 51

Metadata

Authors
Chung, S.-C., Pujades-Rodriguez, M., Duyx, B., Denaxas, S. C., Pasea, L., Hingorani, A., Timmis, A., Williams, B., & Hemingway, H.
Affiliations
  • Health Data Research UK (GB)
  • Maastricht University (NL)
  • National Institute for Health and Care Research (GB)
Corresponding author
Chung, Sheng-Chia
Venue
PLOS ONE
Published
2018-09-05
Volume
13
Issue
9
Pages
e0202359
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2890722022
Cited by
51
References
46
Citations by year
2026: 7 · 2025: 10 · 2024: 9 · 2023: 7 · 2022: 13 · 2021: 1 · 2020: 4
FWCI
0.94
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
  • Research Publications (Maastricht University) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • UCL Discovery (University College London) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
Funders
  • Medical Research Council (MR/M015084/1)
  • National Institute for Health Research
  • NIHR University College London Hospitals / UCL Biomedical Research Centre.
  • Wellcome Trust (MR/K006584/1)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
Keywords
blood pressure control, hypertension, cardiovascular disease, cardiovascular mortality, myocardial infarction, stroke, heart failure, newly diagnosed hypertension, antihypertensive efficacy
MeSH terms
Adult, Aged, Antihypertensive Agents, Blood Pressure, Blood Pressure Determination, Cardiovascular Diseases, Female, Humans, Hypertension, Male, Middle Aged, Risk Factors, Time Factors, Cohort Studies, Survival Rate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Time spent at blood pressure target and the risk of death and cardiovascular diseases. https://app.cochat.ai/papers/10.1371/journal.pone.0202359
The paper
Chung, S.-C., Pujades-Rodriguez, M., Duyx, B., Denaxas, S. C., Pasea, L., Hingorani, A., Timmis, A., Williams, B., & Hemingway, H. (2018). Time spent at blood pressure target and the risk of death and cardiovascular diseases. PLOS ONE. https://doi.org/10.1371/journal.pone.0202359

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.